| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 236,736 | 206,794 | 121,216 | 144,420 | | Cost of Revenue | 177,798 | 147,764 | 72,526 | 84,263 | | | Gross Profit | 58,938 | 59,030 | 48,690 | 60,157 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,966 | 20,183 | 21,530 | 24,774 | | Non Recurring | 5,000 |
-
| (4,000) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 36,972 | 38,847 | 31,160 | 35,383 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,003) | (37,856) | (8,653) | (7,495) | | Earnings Before Interest And Taxes | 35,681 | 2,802 | 21,512 | 29,581 | | Interest Expense | 16,808 | 17,086 | 16,074 | 16,310 | | Income Before Tax | 18,873 | (14,284) | 5,438 | 13,271 | | Income Tax Expense | 2,654 | (6,338) | 2,338 | 1,026 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,303 | (7,946) | 3,100 | 12,245 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 16,219 | (7,946) | 3,100 | 12,245 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $16,219 | ($7,946) | $3,100 | $12,245 |
|
0.11% Nasdaq 0.00%
Income Statement
